Evidence map›Paper›PMID 35599048›Full record

ArticleJournal francais d'ophtalmologie2022

Bilateral multifocal central serous retinopathy following mRNA COVID-19 vaccine.

N Mechleb, Z Khoueir, A Assi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal francais d'ophtalmologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

N MechlebFaculty of Medicine, Saint-Joseph University, Beirut, Lebanon; Beirut Eye and ENT Specialist Hospital, Beirut, Lebanon. Electronic address: mechleb.nicole@gmail.com.
Z KhoueirFaculty of Medicine, Saint-Joseph University, Beirut, Lebanon; Beirut Eye and ENT Specialist Hospital, Beirut, Lebanon; Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, United States.
A AssiBeirut Eye and ENT Specialist Hospital, Beirut, Lebanon; Beirut Eye Clinic, Beirut, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a case of acute bilateral multifocal CSCR in a young healthy Caucasian female occurring 3 days after receiving the first dose of the Pfizer-BioNTech BNT162b2 COVID-19 mRNA vaccine. The true incidence of this adverse reaction might be underreported in asymptomatic unilateral or paracentral cases. We believe that the post-COVID-19 vaccination occurrence of CSCR is not a sufficient reason to withhold the second dose of the vaccine. Further studies are required to ascertain the best way to prevent and manage this complication.

Indexed as

BNT162 VaccineCentral Serous ChorioretinopathyCOVID-19FemaleHumansBNT162 VaccineCentral serous chorioretinopathyChoriorétinopathie séreuse centraleChoroidChoroïdeCOVID-19Effet secondairesPfizer-BioNTech mRNA vaccineRetinaRétineSide effectsVaccin ARN-m Pfizer-BioNTech

Identifiers

PMID35599048
PMCPMC9046098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.